|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Fluvoxamine, Serum/Plasma
Test Code30529
Preferred Specimen
Red Top

Minimum Volume
0.4 mL


Other Acceptable Specimens
Plasma
Instructions
Promptly centrifuge and separate serum or plasma into a plastic screw capped vial using approved guidelines
Transport Temperature
Refrigerated
Specimen Stability
Room temperature: Not Stable
Refrigerated: 30 days
Frozen: 90 days
Refrigerated: 30 days
Frozen: 90 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum separator tube (SST) • Polymer gel separation tube (PST)
Methodology
High Performance Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
FDA Status
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Setup Schedule
Set up: As needed; Report available: 4 days after setup
Reference Range
See Laboratory Report
Clinical Significance
Therapeutic drug monitoring.

